Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]
150 MG/ML · Injection · injection
A form of lanadelumab-flyo →
2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] — Drugs used in hereditary angioedema. Strength, form, class, interactions & more.
![2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=15f99d8c-efe7-4f7d-aa20-0d0f1e30c6e8&name=lanadelumab-01.jpg)
Active ingredient
Classification
Drug interactions
No dedicated drug interaction studies have been conducted for lanadelumab-flyo, but it can affect coagulation test results.
- moderateactivated partial thromboplastin time (aPTT) assay — increased aPTT
Real-world adverse events (FAERS)
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication